These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37720619)

  • 1. Computational investigation of unsaturated ketone derivatives as MAO-B inhibitors by using QSAR, ADME/Tox, molecular docking, and molecular dynamics simulations.
    El Aissouq A; Bouachrine M; Ouammou A; Khalil F
    Turk J Chem; 2022; 46(3):687-703. PubMed ID: 37720619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
    El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
    J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposing Novel MAO-B Hit Inhibitors Using Multidimensional Molecular Modeling Approaches and Application of Binary QSAR Models for Prediction of Their Therapeutic Activity, Pharmacokinetic and Toxicity Properties.
    Is YS; Durdagi S; Aksoydan B; Yurtsever M
    ACS Chem Neurosci; 2018 Jul; 9(7):1768-1782. PubMed ID: 29671581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two dimensional-QSAR and molecular dynamics studies of a selected class of aldoxime- and hydroxy-functionalized chalcones as monoamine oxidase-B inhibitors.
    Mathew B; Ravichandran V; Raghuraman S; Rangarajan TM; Abdelgawad MA; Ahmad I; Patel HM; Kim H
    J Biomol Struct Dyn; 2023 Nov; 41(19):9256-9266. PubMed ID: 36411738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
    Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
    Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
    Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
    J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.
    Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A
    Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 3-styrylchromone derivatives as selective monoamine oxidase B inhibitors.
    Takao K; Takemura Y; Nagai J; Kamauchi H; Hoshi K; Mabashi R; Uesawa Y; Sugita Y
    Bioorg Med Chem; 2021 Jul; 42():116255. PubMed ID: 34119696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of new small molecule monoamine oxidase-B inhibitors through pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation studies.
    Kumar S; Ayyannan SR
    J Biomol Struct Dyn; 2023; 41(14):6789-6810. PubMed ID: 35983603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.
    Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT
    Beni Suef Univ J Basic Appl Sci; 2022; 11(1):104. PubMed ID: 36000144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
    Choi JW; Jang BK; Cho NC; Park JH; Yeon SK; Ju EJ; Lee YS; Han G; Pae AN; Kim DJ; Park KD
    Bioorg Med Chem; 2015 Oct; 23(19):6486-96. PubMed ID: 26337020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Styrylchromone derivatives as potent and selective monoamine oxidase B inhibitors.
    Takao K; Endo S; Nagai J; Kamauchi H; Takemura Y; Uesawa Y; Sugita Y
    Bioorg Chem; 2019 Nov; 92():103285. PubMed ID: 31561103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors.
    Mellado M; González C; Mella J; Aguilar LF; Viña D; Uriarte E; Cuellar M; Matos MJ
    Bioorg Chem; 2021 Mar; 108():104689. PubMed ID: 33571810
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ayaz M; Wadood A; Sadiq A; Ullah F; Anichkina O; Ghufran M
    J Biomol Struct Dyn; 2022; 40(20):10230-10238. PubMed ID: 34157942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology modeling, virtual screening, molecular docking, molecular dynamic (MD) simulation, and ADMET approaches for identification of natural anti-Parkinson agents targeting MAO-B protein.
    El Aissouq A; Bouachrine M; Ouammou A; Khalil F
    Neurosci Lett; 2022 Aug; 786():136803. PubMed ID: 35842207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitors.
    Boulaamane Y; Ahmad I; Patel H; Das N; Britel MR; Maurady A
    J Biomol Struct Dyn; 2023 Apr; 41(6):2326-2340. PubMed ID: 35168478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic, Molecular and Computational Aspects of Novel Monoamine Oxidase (MAO) Inhibitors.
    Ramesh M; Dokurugu YM; Thompson MD; Soliman ME
    Comb Chem High Throughput Screen; 2017; 20(6):492-509. PubMed ID: 28294055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitors.
    Evren AE; Nuha D; Dawbaa S; Sağlık BN; Yurttaş L
    Eur J Med Chem; 2022 Feb; 229():114097. PubMed ID: 34998057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.